Novobiocin (Varsity Pharmaceuticals)

N/A

Report date: 2025/06/09 17:38:27
NME

Base Information

Drug NameNovobiocin (Varsity Pharmaceuticals)
Drug Alias NameVP-006 (Varsity Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionDNA polymerase theta inhibitorsHeat shock protein HSP90 inhibitorsBacterial DNA gyrase inhibitors
TargetsDNA polymerase thetaHeat shock protein HSP90Bacterial DNA gyrase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesVarsity Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A